Robert R. Goodwin
Corporate Officer/Principal at Takeda Vaccines (Montana), Inc.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Donald P. Beeman | M | - |
LigoCyte Pharmaceuticals, Inc.
Takeda Vaccines (Montana), Inc.
Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | - |
Robert F. Bargatze | M | - |
LigoCyte Pharmaceuticals, Inc.
Takeda Vaccines (Montana), Inc.
Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | 26 years |
Larry W. Mikkola | M | - |
LigoCyte Pharmaceuticals, Inc.
Takeda Vaccines (Montana), Inc.
Takeda Vaccines (Montana), Inc. Pharmaceuticals: MajorHealth Technology Takeda Vaccines (Montana), Inc. operates as a biopharmaceutical company which focuses on the development of vaccines that prevent human infectious diseases. It specializes in developing vaccines against norovirus, influenza, and respiratory syncytial virus. The firm develops norovirus VLP vaccines that mimic the surface configuration of the live virus without the ability to cause infection, respiratory syncytial virus vaccine that mediates cell entry in its native form for use in anthrax treatment. The company was founded by Robert F. Bargatze on March 13, 2008 and is headquartered in Bozeman, MT. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Ivor Royston | M | 79 |
LigoCyte Pharmaceuticals, Inc.
| 4 years |
Benjamin Auspitz | M | 51 |
LigoCyte Pharmaceuticals, Inc.
| - |
Markus Goebel | M | - |
LigoCyte Pharmaceuticals, Inc.
| - |
Paul M. Mendelman | M | 76 |
LigoCyte Pharmaceuticals, Inc.
| - |
Charles Richardson | M | 72 |
LigoCyte Pharmaceuticals, Inc.
| 12 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 8 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Robert R. Goodwin
- Personal Network